Black Diamond Therapeutics (BDTX) Cash & Equivalents (QoQ) (2019 - 2026)
Black Diamond Therapeutics (BDTX) Cash & Equivalents (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,819.54 Bn | 1,819.48 Bn | - |
| 2 | Akari Therapeutics | 999.93 Bn | 999.93 Bn | - |
| 3 | BeOne Medicines | 473.50 Bn | 468.71 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.06 Bn | 115.81 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.82 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.14 Bn | 62.14 Bn | - |
| 7 | Argenx Se | 54.72 Bn | 49.54 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.24 Bn | 35.23 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.36 Bn | 36.36 Bn | - |
| 10 | Black Diamond Therapeutics | 98.16 Mn | -20.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.26% |
| Dec 31, 2025 | -31.99% |
| Sep 30, 2025 | 2.90% |
| Jun 30, 2025 | -69.53% |
| Mar 31, 2025 | 170.12% |
| Dec 31, 2024 | 55.55% |
| Sep 30, 2024 | -28.61% |
| Jun 30, 2024 | 29.07% |
| Mar 31, 2024 | -54.78% |
| Dec 31, 2023 | -3.03% |
| Sep 30, 2023 | 38.41% |
| Jun 30, 2023 | 7.02% |
| Mar 31, 2023 | 14.06% |
| Dec 31, 2022 | -36.41% |
| Sep 30, 2022 | -3.43% |
| Jun 30, 2022 | 3.32% |
| Mar 31, 2022 | -17.81% |
| Dec 31, 2021 | 41.19% |
| Sep 30, 2021 | 24.86% |
| Jun 30, 2021 | 164.62% |